Relapse-free survival (RFS) of clinical T2-4N0 urothelial bladder carcinoma (UBC) after radical cystectomy (RC), with or without perioperative chemotherapy (POC): Endpoints for clinical trial design Meeting Abstract
| Authors: | Bandini, M.; Briganti, A.; Plimack, E. R.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; Sridhar, S. S.; Sternberg, C. N.; Vaishampayan, U. N.; Theodore, C.; Rosenberg, J. E.; Bellmunt, J.; Galsky, M. D.; Montorsi, F.; Necchi, A. |
| Abstract Title: | Relapse-free survival (RFS) of clinical T2-4N0 urothelial bladder carcinoma (UBC) after radical cystectomy (RC), with or without perioperative chemotherapy (POC): Endpoints for clinical trial design |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 249s |
| Language: | English |
| ACCESSION: | WOS:000442916002062 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4535 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4535 -- Source: Wos |
